SAN FRANCISCO (MarketWatch) -- Possis Medical Inc. said Monday it has received marketing approval from the Food and Drug Administration for its AngioJet Ultra Thrombectomy System, the next-generation ...
Intravenous thrombolysis is the treatment of choice in patients presenting with high- and intermediate-risk pulmonary embolism. The role of percutaneous mechanical pulmonary thrombectomy (PMPT) is not ...
Although the use of primary angioplasty in the acute myocardial infarction (AMI) setting has been shown to achieve TIMI 3 flow in the majority of patients, there are still some instances in which ...
The mechanism in the AngioJet rheolytic thrombectomy (RT) system (Figure 1) involves the delivery of pressurized heparinized saline from the catheter, where saline jets travel backwards creating a low ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. © 2026 American City Business Journals. All rights ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results